A multi-pronged strategy for tackling cancer access problems
Early results show patients experiencing deep and complete response
Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic Cancer Institute takes multi-faceted approach to ensuring clinical trials representation
Previous studies, trial aims and the potential role of immunotherapy
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
A New Standard of Care in Relapsed/Refractory Large B-Cell Lymphoma
Molecular tumor profiling is available to patients
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Advertisement
Advertisement